Companies: 10,795·Total market cap: $144.5T
Panacos Pharmaceuticals, Inc.

Panacos Pharmaceuticals, Inc.

PANCOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$5367
P/E Ratio
52W High$0.0001
52W Low$0.000001

Panacos Pharmaceuticals, Inc.(PANC)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · PANC · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2007-122006-122005-122004-122003-12
Revenue
Revenue$0.18M$0.28M$1.05M$1.34M$1.08M
Cost of Revenue$0.00M$0.00M$0.00M$0.00M$0.00M
Gross Profit$0.18M$0.28M$1.05M$1.34M$1.08M
Gross Margin %(computed)100.00%100.00%100.00%100.00%100.00%
Operating Expenses
R&D Expenses$25.09M$24.55M$19.80M$11.15M$4.46M
G&A Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
Total Operating Expenses($38.84M)($41.41M)($58.94M)($10.63M)($3.25M)
Operating Income$39.02M$41.70M$59.98M$11.97M$4.33M
Operating Margin %(computed)895.21%401.76%
Interest Income$0.00M$0.00M$0.00M$0.00M$0.00M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax$0.00M$0.00M$0.00M$0.00M$0.00M
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($37.46M)($38.11M)($59.08M)($12.04M)($4.51M)
Net Margin %(computed)-900.37%-418.18%
Per Share & EBITDA
EPS (Basic)$-0.70$-0.75$-1.72$-14.51$-2.74
Wtd Avg Shares53.15M50.52M34.42M0.96M1.65M
EBITDA($38.23M)($40.94M)($39.94M)($11.74M)($4.19M)
EBITDA Margin %(computed)-878.23%-388.96%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Panacos Pharmaceuticals, Inc.

关于Panacos Pharmaceuticals, Inc.(PANC)损益表

Panacos Pharmaceuticals, Inc.(PANC)损益表数据来源于SEC Form 10-K及10-Q申报文件。2007财年,PANC实现营收$0.00B,毛利润$0.00B(毛利率100.00%),净利润($0.04B)(净利率-20810.56%)。

常见问题

PANC · 4 问

Panacos Pharmaceuticals, Inc.(PANC)2007财年营收为$0.00B,同比down36.6%。

PANC revenuePANC salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09